Clinical Trials
12 trialsNCT07606612 2026-05-26
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT04381806 2026-05-22
Phase I Study in Advanced Malignancies With 5-ALA
Fox Chase Cancer Center
Phase 1 Suspended
NCT02806388 2026-05-13
IMPACT
National Cancer Centre, Singapore
Recruiting
NCT06874335 2026-05-13
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
Biohaven Pharmaceuticals, Inc.
Phase 1 Recruiting
NCT06956248 2026-05-13
IMPACT-INSPIRE
National Cancer Centre, Singapore
Recruiting
NCT05162755 2026-05-12
S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers
Servier
Phase 1 Completed
NCT06487858 2026-05-11
A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors
BeOne Medicines
Phase 1 Terminated
NCT06014502 2026-05-08
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
ImmunoGenesis
Phase 1 Recruiting
NCT05206942 2026-05-06
Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy
Stanford University
Phase NA Suspended
NCT05645523 2026-05-04
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
St. Jude Children's Research Hospital
Phase EARLY_PHASE1 Recruiting
NCT06619587 2026-05-04
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
Genentech, Inc.
Phase 1 Recruiting
NCT06895681 2026-05-04
UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations
University of California, San Francisco
Not yet recruiting